AAV2-GEC: Advancing Gene Delivery for Precision Treatment of Antibody-Mediated Kidney Diseases

被引：0
|
作者：
Liu, Shuya [1 ]
Wu, Guochao [1 ]
Koerbelin, Jakob [1 ]
Lu, Shun [1 ]
Huber, Tobias B. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
76.
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [31] Gene Expression Assessment in Kidney Transplant Biopsies To Predict Outcomes in Antibody-Mediated Rejection
    Loupy, A.
    Reeve, J.
    Chang, J.
    Hidalgo, L.
    Vernerey, D.
    Hill, G.
    Legendre, C.
    Halloran, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 38 - 38
  • [32] Enhancing precision medicine: Bispecific antibody-mediated targeted delivery of lipid nanoparticles for potential cancer therapy
    Zhang, Yue
    Gu, Xiaoyan
    Huang, Lili
    Yang, Yani
    He, Jun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 654
  • [33] Precision diagnostics of chronic antibody-mediated rejection (cABMR) after kidney transplantation - new diagnostic possibilities
    Kikic, Zeljko
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (19-20) : 583 - 584
  • [34] Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus
    Cha S.
    Lee S.H.
    Kang S.H.
    Hasan M.N.
    Kim Y.J.
    Cho S.
    Lee Y.-K.
    Biomaterials Research, 22 (1)
  • [35] AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases
    Colella, Pasqualina
    Auricchio, Alberto
    CURRENT GENE THERAPY, 2010, 10 (05) : 371 - 380
  • [36] CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection
    Doberer, Konstantin
    Klaeger, Johannes
    Gualdoni, Guido A.
    Mayer, Katharina A.
    Eskandary, Farsad
    Farkash, Evan A.
    Agis, Hermine
    Reiter, Thomas
    Reindl-Schwaighofer, Roman
    Wahrmann, Markus
    Cohen, Gerald
    Haslacher, Helmuth
    Bond, Gregor
    Simonitsch-Klupp, Ingrid
    Halloran, Philip F.
    Boehmig, Georg A.
    TRANSPLANTATION, 2021, 105 (02) : 451 - 457
  • [37] Daratumumab for treatment of antibody-mediated rejection after ABO-incompatible kidney transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    SWISS MEDICAL WEEKLY, 2019, : 14S - 15S
  • [38] The Analysis of Graft Outcomes Following Treatment in Chronic Antibody-Mediated Rejection in Kidney Transplantation
    Park, J. B.
    Kim, Y. H.
    Chung, Y. S.
    Song, K. B.
    Jung, J. H.
    Kim, S. -C.
    Han, D. J.
    TRANSPLANTATION, 2012, 94 (10) : 1052 - 1052
  • [39] Intensive Plasmapheresis and Intravenous Immunoglobulin for Treatment of Antibody-Mediated Rejection After Kidney Transplant
    Ruangkanchanasetr, Prajej
    Satirapoj, Bancha
    Termmathurapoj, Sumeth
    Namkhanisorn, Kesinee
    Suaywan, Kongsak
    Nimkietkajorn, Veerapatr
    Luesutthiviboon, Lersan
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 (04) : 328 - 333
  • [40] Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2019, 9 (03): : 149 - 157
12345